Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8767112 | Revista Clínica Española | 2018 | 7 Pages |
Abstract
Fabry disease is a lysosomal condition with systemic clinical expression, caused by the tissue deposit of globotriaosylceramide, due to a deficit in its degradation. As with most lysosomal diseases, the presence of a mutation in a gene does not explain the pathophysiological disorders shown by patients. We conducted a comprehensive review of the pathogenic mechanisms that occur in Fabry disease.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
S. Olivera-González, C. Josa-Laorden, M.A. Torralba-Cabeza,